Qiagen Nv (QGEN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering QGEN.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
QGEN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for QGEN as an investment opportunity.
- QGEN has a greater number of analysts covering the stock than 86.1% of all US stocks.
- Qiagen Nv's percentage of analysts bullish on the stock is higher than 14.29% of Pharmaceutical Products stocks.
- Qiagen Nv's upside potential (average analyst target price relative to current price) is higher than 83.7% of stocks in the large market cap category.
- The percent of analysts bearish on the stock of QGEN is less than 16.59% of Pharmaceutical Products stocks.
- Qiagen Nv's average analyst price target is higher than 82.57% of Pharmaceutical Products stocks.
- The variance in analysts' estimates of QGEN is less than 75.88% of stocks in the large market cap category.
- QGEN has a less change in bullishness amongst analysts than nearly 100% of all US stocks.
Make investment decisions regarding QGEN using the data that counts. Try POWR Ratings for free.